KR102328203B1 - Fermented Orostachys japonicus water extract and method of manufacturing the same to improve fuction of dameged liver by oxidative stress - Google Patents

Fermented Orostachys japonicus water extract and method of manufacturing the same to improve fuction of dameged liver by oxidative stress Download PDF

Info

Publication number
KR102328203B1
KR102328203B1 KR1020190119179A KR20190119179A KR102328203B1 KR 102328203 B1 KR102328203 B1 KR 102328203B1 KR 1020190119179 A KR1020190119179 A KR 1020190119179A KR 20190119179 A KR20190119179 A KR 20190119179A KR 102328203 B1 KR102328203 B1 KR 102328203B1
Authority
KR
South Korea
Prior art keywords
wasong
extract
oxidative stress
fermented
liver
Prior art date
Application number
KR1020190119179A
Other languages
Korean (ko)
Other versions
KR20200035901A (en
Inventor
서정훈
신동규
차정단
고은실
조상민
정지혜
Original Assignee
제너럴바이오(주)
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 제너럴바이오(주) filed Critical 제너럴바이오(주)
Publication of KR20200035901A publication Critical patent/KR20200035901A/en
Application granted granted Critical
Publication of KR102328203B1 publication Critical patent/KR102328203B1/en

Links

Images

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18Magnoliophyta (angiosperms)
    • A61K36/185Magnoliopsida (dicotyledons)
    • A61K36/41Crassulaceae (Stonecrop family)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/16Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K2236/00Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
    • A61K2236/10Preparation or pretreatment of starting material
    • A61K2236/19Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Organic Chemistry (AREA)
  • Botany (AREA)
  • Medical Informatics (AREA)
  • Microbiology (AREA)
  • Mycology (AREA)
  • Epidemiology (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)

Abstract

본 발명은 산화적 스트레스에 의한 간손상 개선용 와송 추출물에 관한 것으로, 더욱 상세하게는 와송 발효추출물을 유효성분으로 함유하는 산화적 스트레스로 인한 간손상의 개선용 식품 조성물에 관한 것이다.
또한, 본 발명은 와송 추출물의 제조방법에 관한 것으로, 와송을 30℃에서 5일간 저온 건조하는 단계; 상기 건조된 와송을 분말시키는 단계; 상기 와송 분말에 락토바실러스 플란타룸(Lactobacillus plantarum)과 과즙 배지를 첨가하여 106~107 cells/ml의 농도를 유지 시킨 균주 배양액을 0.5㎖ 접종한 뒤 30℃의 항온배양기와 진탕배양기에서 정치 배양하는 단계를 포함하여 구성된다.
이에 따라,tBHP에 의한 산화적 스트레스로부터 간을 보호하고 간의 기능을 개선하는 효과를 가질 수 있다.
The present invention relates to a Wasong extract for improving liver damage caused by oxidative stress, and more particularly, to a food composition for improving liver damage due to oxidative stress containing the Wasong fermented extract as an active ingredient.
In addition, the present invention relates to a method for producing a Wasong extract, comprising the steps of: drying the Wasong at 30 ° C. for 5 days at a low temperature; powdering the dried wasong; Lactobacillus plantarum ( Lactobacillus plantarum ) and fruit juice medium were added to the wasong powder to inoculate 0.5 ml of a strain culture solution maintaining a concentration of 10 6 to 10 7 cells/ml, and then stand still in an incubator at 30° C. and a shaker incubator. It comprises the step of culturing.
Accordingly, it may have the effect of protecting the liver from oxidative stress caused by tBHP and improving the function of the liver.

Description

산화적 스트레스에 의한 간손상 개선용 와송 발효추출물 및 이의 제조방법 {Fermented Orostachys japonicus water extract and method of manufacturing the same to improve fuction of dameged liver by oxidative stress}Wasong fermented extract and method of manufacturing the same to improve function of dameged liver by oxidative stress}

본 발명은 산화적 스트레스에 의한 발생하는 간손상을 개선할 수 있는 와송 발효추출물 및 이의 제조방법에 관한 것으로, 더욱 상세하게는 와송 추출물을 발효시킨 발효물을 이용하여 활성산소 등으로 인한 산화적 스트레스에 의해 간의 손상을 예방하거나 손상된 간을 개선할 수 있는 와송 발효추출물 및 이의 제조방법에 관한 것이다. The present invention relates to a fermented Wasong extract capable of improving liver damage caused by oxidative stress and a method for preparing the same, and more particularly, to oxidative stress caused by active oxygen, etc. using a fermented product of the Wasong extract. To prevent liver damage or to improve the damaged liver by Wasong fermented extract and a manufacturing method thereof.

간은 탄수화물, 아미노산 및 단백질, 지방을 대사하며 체내로 들어온 독성물질을 분해하는 등 다수의 대사작용을 담당하고 있는 인체의 중요한 기관으로 간의 기능이 저하되면 여러 임상학적 문제가 발생한다. 간 손상의 원인으로는 알코올, 흡연, 바이러스 감염, 독물 중독 등 여러 가지를 들 수 있다. 특히, 활성산소종 (Reactive oxygen species, ROS)에 의해 tert-부틸 하이드로퍼옥사이드(tert-Butyl hydroperoxide, 이하 ‘tBHP’라 한다)가 생성되어 지질과산화를 일으켜 간에 산화적 손상을 준다.The liver is an important organ in the human body that is responsible for a number of metabolic processes, such as metabolizing carbohydrates, amino acids, proteins, and fats and decomposing toxic substances that enter the body. There are many causes of liver damage, including alcohol, smoking, viral infections, and poison poisoning. In particular, tert-butyl hydroperoxide (hereinafter referred to as 'tBHP') is generated by reactive oxygen species (ROS), which causes lipid peroxidation and oxidative damage to the liver.

산화스트레스는 빠르게 변화하는 현대 사회를 살아가는 인간에게 나타나는 대표적인 질병의 원인이 되는 것으로 공해물질 및 오염물질, 잘못된 식습관 또는 정신적 스트레스 등에 의하여 유발된다. 특히 tBHP는 산화스트레스를 직접적으로 유발하는 물질로 널리 알려져 있으며, 세포 내에서 활성산소종(reactive oxygen species; ROS)를 생성하고, 이는 다양한 질병들의 기본적인 원인으로 작용하여 노화, 암, 면역저하의 매개자 역할을 한다. 최근 ROS에 대하여 다양한 연구들이 보고되고 있으며, 특히 간, 신장 등의 인체 기관에 미치는 산화스트레스에 대한 연구는 많이 이루어지고 있다.Oxidative stress is a cause of typical diseases that appear in humans living in a rapidly changing modern society, and is caused by pollutants and pollutants, wrong eating habits, or mental stress. In particular, tBHP is widely known as a substance that directly induces oxidative stress, and generates reactive oxygen species (ROS) in cells, which act as a basic cause of various diseases and are mediators of aging, cancer, and immunosuppression. plays a role Recently, various studies on ROS have been reported, and in particular, many studies on oxidative stress on human organs such as liver and kidneys have been conducted.

본 발명자들은 산화적 스트레스로 인하여 발생하는 간손상에 대하여 와송 추출물과 와송 발효추출물이 효과가 있는 것을 확인하고 본 발명을 완성하였다. The present inventors confirmed that the Wasong extract and the Wasong fermented extract are effective against liver damage caused by oxidative stress and completed the present invention.

KR 10-0900343 B1 (2009. 05. 25.)KR 10-0900343 B1 (2009. 05. 25.)

본 발명에서 해결하고자 하는 과제는 천연 소재인 와송을 이용하여 산화적 스트레스로 인해 발생된 간손상을 예방하거나 개선할 수 있는 식품조성물을 제공하는 것이다.An object to be solved in the present invention is to provide a food composition capable of preventing or improving liver damage caused by oxidative stress using wasong, a natural material.

위와 같은 과제를 해결하기 위한 본 발명에 따른 조성물은 산화적 스트레스에 의한 간손상 개선용 와송 추출물 및 이의 제조방법을 제공하는데 그 기술적 특징이 있다. The composition according to the present invention for solving the above problems provides a Wasong extract for improving liver damage due to oxidative stress and a method for preparing the same, and has its technical characteristics.

본 발명은 와송을 주재료로하여 추출물을 얻어 Lactobacillus plantarum으로 발효한 발효액으로 tBHP에 의한 산화적 스트레스로부터 간을 보호하고 간의 기능을 개선하는 효과를 가질 수 있다. The present invention is a fermented broth fermented with Lactobacillus plantarum by obtaining an extract from Wasong as a main material, and can have the effect of protecting the liver from oxidative stress caused by tBHP and improving the liver function.

도 1은 와송 추출액(OJD)과 와송 발효추출물(FOJD)의 HepG2 간세포에 대한 세포독성 결과를 나타낸 그래프
도 2는 와송 추출액(OJD)과 와송 발효추출물(FOJD)이 t-BHP에 의해 유발된 HepG2 간세포의 세포독성 억제 결과를 나타낸 그래프
도 3은 와송 추출액(OJD)과 와송 발효추출물(FOJD)이 HepG2 간세포의 활성산소종 생성에 미치는 효과를 나타낸 그래프
도 4는 와송 추출액(OJD)과 와송 발효추출물(FOJD)이 HepG2 간세포의 GSH 생성에 미치는 효과를 나타낸 그래프
도 5는 와송 추출액(OJD)과 와송 발효추출물(FOJD)이 HepG2 간세포의 MDA 생성에 미치는 효과를 나타낸 그래프
도 6 내지 도 19는 와송 추출액(OJD) 또는 와송 발효추출물(FOJD)의 산화스트레스와 관련된 유전자 발현 억제 효과를 나타낸 그래프
1 is a graph showing the cytotoxicity results for HepG2 hepatocytes of Wasong extract (OJD) and Wasong fermentation extract (FOJD)
Figure 2 is a graph showing the results of inhibition of cytotoxicity of HepG2 hepatocytes induced by t-BHP by Wasong extract (OJD) and Wasong fermentation extract (FOJD);
Figure 3 is a graph showing the effect of Wasong extract (OJD) and Wasong fermentation extract (FOJD) on the production of reactive oxygen species in HepG2 hepatocytes
Figure 4 is a graph showing the effect of Wasong extract (OJD) and Wasong fermentation extract (FOJD) on GSH production of HepG2 hepatocytes
5 is a graph showing the effect of Wasong extract (OJD) and Wasong ferment extract (FOJD) on MDA production of HepG2 hepatocytes
6 to 19 are graphs showing the gene expression inhibition effect related to oxidative stress of Wasong extract (OJD) or Wasong fermentation extract (FOJD)

본 명세서 및 청구범위에 사용된 용어나 단어는 "발명자는 그 자신의 발명을 가장 최선의 방법으로 설명하기 위해 용어의 개념을 적절하게 정의할 수 있다는 원칙"에 입각하여 본 발명의 기술적 사상에 부합하는 의미와 개념으로 해석되어야지, 통상적이거나 사전적인 의미로 한정해서 해석되서는 안 된다.The terms or words used in the present specification and claims conform to the technical idea of the present invention based on the "principle that the inventor can appropriately define the concept of a term in order to best describe his invention" It should be interpreted as the meaning and concept that

따라서 본 명세서에 기재된 실시예와 도면에 도시된 구성은 본 발명의 가장 바람직한 실시예에 불과할 뿐이고, 본 발명의 기술적 사상을 모두 대변하는 것은 아니므로, 본 출원시점에 있어서 이들을 대체할 수 있는 다양한 균등물과 변형 예들이 있을 수 있음을 이해해야 한다.Therefore, the embodiments described in this specification and the configurations shown in the drawings are only the most preferred embodiments of the present invention, and do not represent all the technical ideas of the present invention, so various equivalents that can replace them at the time of the present application It should be understood that there may be water and variations.

와송(Orostachys japonicus)은 바위솔로 불리는 돌나물과의 다년생 초본식물이다. 간 질환을 비롯한 여러 질병을 치료하기 위해 한국 및 아시아 국가에서 한방 약재로 쓰이며 산화적 스트레스에 의한 신경세포의 손상을 억제하며 간의 약물대사 효소 및 지질과산화를 조절한다. 와송에 존재하는 성분으로는 플라보노이드 (Flavonoid), 트리테르펜 (Triterpene), 스테로이드 (Steroid) 성분 등 총 31종의 화학성분이 규명되었다.Wasong ( Orostachys japonicus) is a perennial herbaceous plant of the sedumaceae family called rock brush. It is used as a herbal medicine in Korea and Asian countries to treat various diseases including liver disease. A total of 31 chemical components, including flavonoids, triterpenes, and steroids, were identified as the components present in Wasong.

락토바실러스 플란타룸(Lactobacillus plantarum)은 동형 또는 이형 발효를 하는 젖산 간균으로서 사람을 포함한 동물의 장관 및 유제품이나 채소의 발효과정에서 흔히 볼 수 있다. 락토바실러스속 미생물은 장내 pH를 산성으로 유지시켜 대장균(E. coli)이나 클로스트리디움(Clostridium)과 같은 유해균의 번식을 억제하고 설사와 변비를 개선할 뿐만 아니라 비타민 합성, 항암 작용, 혈청콜레스테롤 저하 등의 역할을 하는 것으로 알려져 있다. 젖산 간균에 의해 생산되는 아시도필린(acidophillin)은 이질균, 살모넬라균, 포도상 구균, 대장균 등의 성장을 저해한다고 알려져 있다. 또한, 설사 원인균의 증식을 억제하고 장내균총을 정상화시켜 설사를 멈추게 하는 작용을 한다. Lactobacillus plantarum ( Lactobacillus plantarum ) is a lactic acid bacillus performing homozygous or heterozygous fermentation, and is commonly found in the intestinal tract of animals, including humans, and in the fermentation process of dairy products or vegetables. Microorganisms of the genus Lactobacillus maintain the pH of the intestine to be acidic, suppressing the reproduction of harmful bacteria such as E. coli and Clostridium, and improving diarrhea and constipation, as well as vitamin synthesis, anticancer action, and lowering of serum cholesterol. It is known to play a role. Acidophillin produced by lactic acid bacilli is known to inhibit the growth of Shigella, Salmonella, Staphylococcus aureus, Escherichia coli, and the like. In addition, it inhibits the proliferation of diarrhea-causing bacteria and normalizes the intestinal flora to stop diarrhea.

실시예 1: 와송 추출물의 제조Example 1: Preparation of Wasong Extract

서울 경동시장의 한약방에서 구입한 와송을 충분히 세척한 후 초미립자분쇄기(Jet Mill, Ducksan, SiHeung, Korea)를 이용하여 미세 분말로 세분한 다음, 100g/L가 되도록 70% 에탄올을 첨가하여 5시간씩 3회 환류추출하고 냉침한 후, 와트만(whatman) #10 여과지로 여과하였다. 이렇게 얻은 여과액을 다시 0.25uM의 여과기를 이용하여 최종 여과하였다. 여과된 추출물을 50℃ 이하에서 감압농축하여 와송 추출물을 제조하였다.After thoroughly washing the wasong purchased at the oriental medicine room in Gyeongdong Market, Seoul, use an ultrafine particle grinder (Jet Mill, Ducksan, SiHeung, Korea) to break it into fine powder, and then add 70% ethanol to 100g/L for 5 hours each. After extraction under reflux three times and cooling, it was filtered with Whatman #10 filter paper. The filtrate thus obtained was again finally filtered using a filter of 0.25 uM. The filtered extract was concentrated under reduced pressure at 50° C. or less to prepare a Wasong extract.

실시예 2: 와송 발효추출물의 제조Example 2: Preparation of Wasong Fermented Extract

서울 경동시장의 한약방에서 구입한 와송을 수세한 뒤, 건조기 (HDG-222, HyunDaeEnetech, HwaSung, Korea)를 이용하여 30℃에서 5일간 저온 건조한 후, 초미립자분쇄기(Jet Mill, Ducksan, SiHeung, Korea)를 이용하여 미세 분말로 세분하여 5g을 칭량하였다.After washing the wasong purchased at the oriental medicine store in Gyeongdong Market, Seoul, dry it at 30°C for 5 days at a low temperature using a dryer (HDG-222, HyunDaeEnetech, HwaSung, Korea), and then use an ultra-fine particle grinder (Jet Mill, Ducksan, SiHeung, Korea) 5 g was weighed by subdividing into fine powder using

와송 분말에 액상 발효된 락토바실러스 플란타룸(Lactobacillus plantarum)과 과즙 배지를 첨가하여 106~107 cells/ml의 농도를 유지 시킨 균주 배양액을 0.5㎖ 접종한 뒤 30℃의 항온배양기와 진탕배양기에서 정치 배양하였다. 발효 동안 샘플을 간헐적으로 흔들어 주었다.After inoculating 0.5 ml of the strain culture medium maintaining the concentration of 10 6 ~ 10 7 cells/ml by adding liquid fermented Lactobacillus plantarum and fruit juice medium to Wasong powder, incubator at 30℃ and shaking incubator was politically cultured in Samples were shaken intermittently during fermentation.

실험예 1. 폴리페놀 및 플라보노이드 함량 측정Experimental Example 1. Measurement of polyphenol and flavonoid content

1-1. 실험 과정1-1. experimental process

실시예 1의 와송 추출물과 실시예 2의 와송 발효추출물에 함유된 폴리페놀과 플라보노이드의 함량을 측정하였다. 실시예 2의 와송 발효추출물의 경우 발효일 수(1일-5일)에 따라 각각 함량을 측정하였다. The content of polyphenols and flavonoids contained in the Wasong extract of Example 1 and the Wasong fermented extract of Example 2 was measured. In the case of the Wasong fermented extract of Example 2, the content was measured according to the number of fermentation days (1-5 days).

1-2. 실험 결과1-2. Experiment result

Figure 112019098811124-pat00001
Figure 112019098811124-pat00001

표 1에 표시된 바와 같이 와송 추출물(OJD) 대비 1일 발효시킨 와송 발효추출물(FOJD) 경우 폴리페놀 함량이 더 높게 측정된 것을 알 수 있다. 다만, 발효일수가 증가할 수록 폴리페놀의 함량은 감소하였다.As shown in Table 1, it can be seen that the polyphenol content was higher in the case of the Wasong fermented extract (FOJD) fermented for 1 day compared to the Wasong extract (OJD). However, as the number of fermentation days increased, the polyphenol content decreased.

플라보노이드의 경우 발효 전과 후의 차이가 분명하게 나타나는 것을 알 수 있다.In the case of flavonoids, it can be seen that there is a clear difference between before and after fermentation.

실험예 2. 와송 추출물 및 와송 발효추출물의 주요 성분 분석Experimental Example 2. Analysis of major components of Wasong extract and fermented Wasong extract

2-1. 실험 과정2-1. experimental process

실시예 1의 와송 추출물과 실시예 2의 와송 발효추출물의 주요 구성성분 함량 분석을 실시하였다. 검출된 주요성분으로는 갈산(gallic acid), 카테킨(catechin), 에피카테킨(epicatechin), 에피칼로카테킨 갈레이트(epigallocatechin gallate, EGCG), 에피카테킨 갈레이트(epicatechin gallate), 아이소퀘르세틴(isoquercetin)이 있다. The main component content analysis of the Wasong extract of Example 1 and the Wasong fermented extract of Example 2 was performed. The main components detected were gallic acid, catechin, epicatechin, epigallocatechin gallate (EGCG), epicatechin gallate, and isoquercetin.

2-2. 실험 결과2-2. Experiment result

Figure 112019098811124-pat00002
Figure 112019098811124-pat00002

표 2에 표시된 바와 같이 카테킨과 에피카테킨만이 발효시간이 지남에 따라 그 함량이 증가한 것을 알 수 있고, 그 외의 다른 성분은 발효가 됨에 따라 감소하는 것을 알 수 있다. 또한, 카테킨과 에피카테킨은 발효 전보다 발효 후에 그 함량이 증가한 것을 알 수 있다. As shown in Table 2, it can be seen that only catechin and epicatechin content increased with the passage of fermentation time, and it can be seen that other components decreased as the fermentation progressed. In addition, it can be seen that the contents of catechin and epicatechin increased after fermentation than before fermentation.

실험예 3. DPPH 및 ABTS 라디칼 소거능 분석Experimental Example 3. DPPH and ABTS radical scavenging activity analysis

3-1. 실험 과정3-1. experimental process

실시예 1의 와송 추출물 및 실시예 2의 와송 발효추출물의 DPPH 및 ABTS 라디칼 소거능 분석을 실시하였다. 양성 대조군으로는 아스코빅산(ascorbic acid)이 이용되었다. DPPH and ABTS radical scavenging activity of the Wasong extract of Example 1 and the Wasong fermented extract of Example 2 was analyzed. As a positive control, ascorbic acid was used.

3-2. 실험 결과3-2. Experiment result

Figure 112019098811124-pat00003
Figure 112019098811124-pat00003

표 3에 표시된 바와 같이 와송 추출물(OJD)의 경우 아스코빅산보다 적은양으로도 DPPH 라디칼 소거능이 우수한 것을 알 수 있고, ABTS 라디칼 소거능은 거의 절반 수준으로 우수한 것을 알 수 있다.As shown in Table 3, in the case of Wasong extract (OJD), it can be seen that even with a smaller amount than ascorbic acid, the DPPH radical scavenging ability is excellent, and the ABTS radical scavenging ability is excellent at almost half.

와송 발효추출물(FOJD)의 경우 발효기간이 증가할 수록 DPPH 및 ABTS 라디칼 소거에 요구되는 추출물의 용량이 증가하는 것을 알 수 있다. In the case of Wasong fermented extract (FOJD), it can be seen that the capacity of the extract required for scavenging DPPH and ABTS radicals increases as the fermentation period increases.

실험예 4. 와송 발효추출물이 간세포 생존에 미치는 효과 평가 Experimental Example 4. Evaluation of the effect of Wasong fermented extract on hepatocyte survival

4-1. 실험 과정4-1. experimental process

HepG2 간세포에 상이한 농도의 와송추출물(OJD)과 와송 발효추출물(FOJD)을 0~500 ㎍/mL의 농도로 처리한 뒤, tBHP를 첨가하고 4시간 동안 반응하였다.HepG2 hepatocytes were treated with different concentrations of wasong extract (OJD) and fermented wasong extract (FOJD) at a concentration of 0-500 μg/mL, then tBHP was added and reacted for 4 hours.

4-2. 실험 결과4-2. Experiment result

도 1에 도시된 바와 같이 와송 추출물(OJD)은 전 농도 구간에서 세포독성을 거의 보이지 않았으나, 와송 발효추출물(FOJD)은 250㎍/㎖의 농도까지는 세포독성을 거의 보이지 않다가 500㎍/㎖의 농도부터 세포독성을 보이는 것을 알 수 있다. As shown in Figure 1, the Wasong extract (OJD) showed little cytotoxicity in all concentration ranges, but the Wasong fermented extract (FOJD) showed little cytotoxicity up to a concentration of 250㎍/㎖, It can be seen that the concentration shows cytotoxicity.

그리고 도 2에 도시된 바와 같이 tBHP가 처리된 실험군에 세포독성을 유발하여 간세포의 생존율을 약 60-80% 감소시켰다. 그러나 와송 추출물(OJD) 및 와송 발효추출물(FOJD)을 처리한 실험군은 시료의 용량에 의존적(5 ~ 50 ㎍/㎖)으로 세포 생존율이 높았으며 시료를 7.8㎍/㎖로 전처리한 구간에서 세포 생존율이 가장 높았다.And, as shown in FIG. 2, cytotoxicity was induced in the tBHP-treated experimental group, thereby reducing the survival rate of hepatocytes by about 60-80%. However, the experimental group treated with the Wasong extract (OJD) and the Wasong fermented extract (FOJD) had high cell viability in a dose-dependent manner (5 ~ 50 μg/ml), and the cell viability in the section pretreated with the sample at 7.8 μg/ml this was the highest

또한, 와송 발효추출물(FOJD)을 처리한 실험군의 세포 생존율이 와송 추출물(OJD)을 처리한 실험군의 세포 생존율보다 높았다.In addition, the cell viability of the experimental group treated with the Wasong ferment extract (FOJD) was higher than the cell viability of the experimental group treated with the Wasong extract (OJD).

실험예 5. 와송 발효추출물이 활성산소종 생성에 미치는 효과 평가Experimental Example 5. Evaluation of the effect of Wasong fermented extract on the generation of reactive oxygen species

5-1. 실험 과정5-1. experimental process

HepG2 간세포에 와송 발효추출물을 처리하였을 경우, 활성산소종 생성에 미치는 효과를 평가하기 위하여 디클로로디하이드로플루오레세인 디아세테이트(dichlorodihydrofluorescein diacetate, DCFH-DA)를 이용하여 활성산소종의 양을 측정하였다. tBHP로 산화적 스트레스를 유발하여 간염을 유발시킨 HepG2 간세포 1 x 106 cells/ml에 20uM의 DCFH-DA를 처리하여 30분 동안 배양하였다. 배양액을 2500 rpm에서 10분간 원심 분리하여 상층액을 회수한 뒤, 분광형광계 (spectrofluorometer)를 사용하여 여기 파장 485nm 및 방사 파장 523nm에서 측정하여 생성된 디클로로플루오레세인(dichlorofluorescein, DCF)의 형광값을 측정하였다.When the HepG2 hepatocytes were treated with the ferment extract, the amount of reactive oxygen species was measured using dichlorodihydrofluorescein diacetate (DCFH-DA) to evaluate the effect on the generation of reactive oxygen species. HepG2 hepatocytes induced by oxidative stress with tBHP at 1 x 10 6 cells/ml were treated with 20uM DCFH-DA and cultured for 30 minutes. The culture medium was centrifuged at 2500 rpm for 10 minutes to recover the supernatant, and the fluorescence value of dichlorofluorescein (DCF) generated by measuring at an excitation wavelength of 485 nm and an emission wavelength of 523 nm using a spectrofluorometer was measured. measured.

5-2. 실험 결과5-2. Experiment result

도 3에 도시된 바와 같이 활성산소종 생성으로 인한 DCF 형광값은 와송 추출물(OJD)을 처리한 실험군보다 와송 발효추출물(FOJD)을 처리한 실험군에서 농도 의존적으로 감소하였다. 특히, 25~100 ㎍/㎖의 와송 발효추출물(FOJD)을 처리했을 때 활성산소종 생성 억제 효과가 우수한 것을 확인하였다.As shown in FIG. 3, DCF fluorescence value due to the generation of reactive oxygen species was decreased in a concentration-dependent manner in the experimental group treated with the Wasong ferment extract (FOJD) than in the experimental group treated with the Wasong extract (OJD). In particular, it was confirmed that when 25-100 ㎍ / ㎖ of Wasong fermented extract (FOJD) was treated, the inhibitory effect on the production of reactive oxygen species was excellent.

실험예 6. 와송 발효추출물이 GSH 생성에 미치는 효과 평가Experimental Example 6. Evaluation of the effect of Wasong fermented extract on GSH production

6-1. 실험 준비6-1. Experiment preparation

tBHP로 산화적 스트레스를 유발하여 간염을 유발시킨 HepG2간세포의GSH(glutathione) 농도는 엘르만(Ellman)의 방법으로 측정하였다. HepG2 간세포 1 x 106 cells/ml에 0.4% 설포살리실산(sulfosalicylic acid)를 첨가하고 2500 rpm에서 10분간 원심 분리한 후 상층액을 회수하였다. 회수된 상층액 0.3 ㎖를 취하여 디설피드 시약(disulfide reagent) 2.7 ㎖를 넣고 실온에서 20분간 방치한 뒤, 412nm에서 흡광도를 측정하고 표준검량선을 이용하여 정량하였다.The GSH (glutathione) concentration of HepG2 hepatocytes induced by oxidative stress with tBHP to induce hepatitis was measured by Ellman's method. 0.4% sulfosalicylic acid was added to 1 x 106 cells/ml of HepG2 hepatocytes, and the supernatant was recovered after centrifugation at 2500 rpm for 10 minutes. 0.3 ml of the recovered supernatant was taken, 2.7 ml of a disulfide reagent was added, and left at room temperature for 20 minutes. Absorbance was measured at 412 nm and quantified using a standard calibration curve.

6-2. 실험 결과6-2. Experiment result

도 4에 도시된 바와 GSH의 농도는 와송 추출물(OJD)을 처리한 실험군보다 와송 발효추출물(FOJD)을 처리한 실험군에서 농도 의존적으로 증가하였다. 특히, 100 ㎍/㎖의 와송 발효추출물(FOJD)을 처리했을 때 GSH 증가 효과가 우수한 것을 확인하였다.As shown in FIG. 4, the concentration of GSH increased in a concentration-dependent manner in the experimental group treated with the Wasong ferment extract (FOJD) than in the experimental group treated with the Wasong extract (OJD). In particular, it was confirmed that the GSH increasing effect was excellent when 100 ㎍ / ㎖ of Wasong fermented extract (FOJD) was treated.

실험예 7. 와송 발효추출물이 MDA 생성에 미치는 효과 평가Experimental Example 7. Evaluation of the effect of Wasong fermented extract on MDA production

7-1. 실험 과정7-1. experimental process

지질과산화(lipid peroxidation)의 지표인 말론디알데하이드(malondialdehyde, MDA)를 측정하기 위해 다음 실험을 수행하였다. tBHP로 산화적 스트레스를 유발하여 간염을 유발시킨 HepG2 간세포를 37℃, 5% 이산화탄소 배양기에서 배양하였다. 그런 다음, 2500 rpm에서 10분간 원심 분리한 후 상층액을 제거한 뒤, 펠렛(pellet)에 0.37%(w/v) 티오바르비탈산(2-Thiobarbituric acid, TBA) 및 15%(w/v) 트리클로로아세트산(Trichloroacetic acid, TCA)이 포함된 0.25 M 염산(HCl) 용액을 첨가하여 80℃로 15분간 가열하였다. 동량의 부탄올을 첨가하고 10,000 rpm에서 5분간 원심 분리한 뒤, 상층액을 회수하여 530nm의 파장에서 흡광도를 측정하였다.The following experiment was performed to measure malondialdehyde (MDA), an indicator of lipid peroxidation. HepG2 hepatocytes, which induced hepatitis by inducing oxidative stress with tBHP, were cultured at 37°C in a 5% carbon dioxide incubator. Then, after centrifugation at 2500 rpm for 10 minutes, the supernatant was removed, and 0.37% (w/v) thiobarbituric acid (TBA) and 15% (w/v) trichloride were added to the pellet. A 0.25 M hydrochloric acid (HCl) solution containing trichloroacetic acid (TCA) was added and heated to 80° C. for 15 minutes. After adding the same amount of butanol and centrifuging at 10,000 rpm for 5 minutes, the supernatant was recovered and absorbance was measured at a wavelength of 530 nm.

7-2. 실험 결과7-2. Experiment result

도 5에 도시된 바와 같이 MDA의 농도는 와송 추출물(OJD)을 처리한 실험군보다 와송 발효추출물(FOJD)을 처리한 실험군에서 농도 의존적으로 감소하였다. 특히, 100 ㎍/㎖의 와송 발효추출물(FOJD)을 처리했을 때 MDA 생성 억제 효과가 우수한 것을 확인하였다.As shown in FIG. 5 , the concentration of MDA was decreased in a concentration-dependent manner in the experimental group treated with the Wasong ferment extract (FOJD) than in the experimental group treated with the Wasong extract (OJD). In particular, it was confirmed that the MDA production inhibitory effect was excellent when 100 μg/ml of Wasong ferment extract (FOJD) was treated.

실험예 8. 산화스트레스 관련 인자의 mRNA 수준 분석Experimental Example 8. Analysis of mRNA levels of factors related to oxidative stress

8-1. 실험 과정8-1. experimental process

산화스트레스가 발생할 시 증가되는 인자들에 대하여 mRNA 수준에서 분석을 실시하였다. 분석 대상인 유전자들은 AMPKα-1(5' adenosine monophosphate-activated protein kinase-1), AMPKα-2(5' adenosine monophosphate-activated protein kinase-2), ACC-1(acetyl-CoA carboxylase 1), SOD-1(superoxide dismutase 1), SOD-2(superoxide dismutase 2), CAT(catalase), GPX(glutathione peroxidase) 등이다.Factors increased when oxidative stress occurred were analyzed at the mRNA level. The genes to be analyzed are AMPKα-1 (5' adenosine monophosphate-activated protein kinase-1), AMPKα-2 (5' adenosine monophosphate-activated protein kinase-2), ACC-1 (acetyl-CoA carboxylase 1), SOD-1 (superoxide dismutase 1), SOD-2 (superoxide dismutase 2), CAT (catalase), GPX (glutathione peroxidase), and the like.

8-2. 실험 과정8-2. experimental process

1)AMPKα-1 유전자는 도 6에 도시된 바와 같이 tBHP의 존재에 따라 많은 양의 mRNA가 전사되었고, 와송 추출물(OJD)의 농도가 12.5㎍/㎖ 일 시 급격하게 전사량이 감소하였다. 1) In the AMPKα-1 gene, a large amount of mRNA was transcribed according to the presence of tBHP as shown in FIG. 6 , and the transcription amount was rapidly decreased when the concentration of Wasong extract (OJD) was 12.5 μg/ml.

2)AMPKα-1 유전자는 도 7에 도시된 바와 같이 tBHP의 존재에 따라 많은 양의 mRNA가 전사되었고, 와송 발효추출물(FOJD)의 농도가 125㎍/㎖ 일 시 급격하게 전사량이 감소하였다. 2) In the AMPKα-1 gene, a large amount of mRNA was transcribed according to the presence of tBHP as shown in FIG. 7 , and the transcription amount was rapidly reduced when the concentration of Wasong ferment extract (FOJD) was 125 μg/ml.

3)AMPKα-2 유전자는 도 8에 도시된 바와 같이 tBHP의 존재에 따라 많은 양의 mRNA가 전사되었고, 와송 추출물(OJD)의 농도가 6.25㎍/㎖ 일 시 급격하게 전사량이 급감하였고, 12.5㎍/㎖ 일 시 발현량이 0에 수렴하였다.3) In the AMPKα-2 gene, a large amount of mRNA was transcribed according to the presence of tBHP as shown in FIG. 8, and when the concentration of Wasong extract (OJD) was 6.25 μg/ml, the transcription amount sharply decreased, and 12.5 μg The expression level at the time of /ml converged to 0.

4)AMPKα-2 유전자는 도 9에 도시된 바와 같이 tBHP의 존재에 따라 많은 양의 mRNA가 전사되었고, 와송 발효추출물(FOJD)의 농도가 31.3㎍/㎖ 일 시 급격하게 전사량이 감소하였다.4) In the AMPKα-2 gene, a large amount of mRNA was transcribed according to the presence of tBHP as shown in FIG. 9, and when the concentration of Wasong ferment extract (FOJD) was 31.3 μg/ml, the transcription amount was rapidly reduced.

5)ACC-1 유전자는 도 10에 도시된 바와 같이 tBHP의 존재에 따라 많은 양의 mRNA가 전사되었고, 와송 추출물(OJD)의 농도가 3.13㎍/㎖ 일 시 절반 수준으로 감소하였고, 12.5㎍/㎖ 일 시 발현량이 0에 수렴하였다.5) In the ACC-1 gene, a large amount of mRNA was transcribed according to the presence of tBHP as shown in FIG. 10, and the concentration of Wasong extract (OJD) was reduced to half when 3.13 μg/ml, and 12.5 μg/ml. The expression level at the time of ml converged to 0.

6)ACC-1 유전자는 도 11에 도시된 바와 같이 tBHP의 존재에 따라 많은 양의 mRNA가 전사되었고, 와송 발효추출물(FOJD)의 농도가 31.3㎍/㎖ 일 시 급격하게 전사량이 감소하였다.6) As shown in FIG. 11, a large amount of mRNA was transcribed in the ACC-1 gene according to the presence of tBHP, and when the concentration of Wasong ferment extract (FOJD) was 31.3 μg/ml, the transcription amount was rapidly decreased.

7)SOD-1 유전자는 도 12에 도시된 바와 같이 tBHP의 존재에 따라 많은 양의 mRNA가 전사되었고, 와송 추출물(OJD)의 농도가 3.13㎍/㎖ 일 시 1/3 수준으로 감소하였고, 12.5㎍/㎖ 일 시 발현량이 0에 수렴하였다.7) In the SOD-1 gene, a large amount of mRNA was transcribed according to the presence of tBHP as shown in FIG. 12, and the concentration of Wasong extract (OJD) was reduced to 1/3 level when 3.13 μg/ml, 12.5 The expression level at the time of μg/ml converged to 0.

8)SOD-1 유전자는 도 13에 도시된 바와 같이 tBHP의 존재에 따라 많은 양의 mRNA가 전사되었고, 와송 발효추출물(FOJD)의 농도가 62.5㎍/㎖ 일 시 급격하게 전사량이 감소하였다.8) As shown in FIG. 13 , a large amount of mRNA was transcribed in the SOD-1 gene according to the presence of tBHP, and when the concentration of Wasong ferment extract (FOJD) was 62.5 μg/ml, the transcription amount was rapidly reduced.

9)SOD-2 유전자는 도 14에 도시된 바와 같이 tBHP의 존재에 따라 많은 양의 mRNA가 전사되었고, 와송 추출물(OJD)의 농도가 3.13㎍/㎖ 일 시 1/3 수준으로 감소하였고, 12.5㎍/㎖ 일 시 발현량이 0에 수렴하였다.9) In the SOD-2 gene, a large amount of mRNA was transcribed according to the presence of tBHP as shown in FIG. 14, and the concentration of Wasong extract (OJD) was decreased to 1/3 level when 3.13 μg/ml, 12.5 The expression level at the time of μg/ml converged to 0.

10)SOD-2 유전자는 도 15에 도시된 바와 같이 tBHP의 존재에 따라 많은 양의 mRNA가 전사되었고, 와송 발효추출물(FOJD)의 농도가 62.5㎍/㎖ 일 시 절반수준으로 전사량이 감소하였다.10) As shown in FIG. 15 , a large amount of mRNA was transcribed in the SOD-2 gene according to the presence of tBHP, and when the concentration of Wasong ferment extract (FOJD) was 62.5 μg/ml, the transcription amount was reduced to half.

11)CAT 유전자는 도 16에 도시된 바와 같이 tBHP의 존재에 따라 많은 양의 mRNA가 전사되었고, 와송 추출물(OJD)의 농도가 3.13㎍/㎖ 일 시 급격하게 감소하였고, 12.5㎍/㎖ 일 시 발현량이 0에 수렴하였다.11) In the CAT gene, a large amount of mRNA was transcribed according to the presence of tBHP as shown in FIG. 16 , and the concentration of Wasong extract (OJD) was rapidly decreased when 3.13 μg/ml and 12.5 μg/ml. The expression level converged to 0.

12)CAT 유전자는 도 17에 도시된 바와 같이 tBHP의 존재에 따라 많은 양의 mRNA가 전사되었고, 와송 발효추출물(FOJD)의 농도가 31.3㎍/㎖ 일 시 절반수준으로 전사량이 감소하였다.12) In the CAT gene, a large amount of mRNA was transcribed according to the presence of tBHP as shown in FIG. 17, and when the concentration of Wasong ferment extract (FOJD) was 31.3 μg/ml, the transcription amount was reduced to half.

13)GPX 유전자는 도 18에 도시된 바와 같이 tBHP의 존재에 따라 많은 양의 mRNA가 전사되었고, 와송 추출물(OJD)의 농도가 3.13㎍/㎖ 일 시 급격하게 감소하였고, 12.5㎍/㎖ 일 시 발현량이 거의 0에 수렴하였다.13) In the GPX gene, a large amount of mRNA was transcribed according to the presence of tBHP as shown in FIG. 18, and the concentration of Wasong extract (OJD) was rapidly decreased when 3.13 μg/ml and 12.5 μg/ml. The expression level converges to almost zero.

14)GPX 유전자는 도 19에 도시된 바와 같이 tBHP의 존재에 따라 많은 양의 mRNA가 전사되었고, 와송 발효추출물(FOJD)의 농도가 62.5㎍/㎖ 일 시 절반수준으로 전사량이 감소하였다.14) As shown in FIG. 19 , a large amount of mRNA was transcribed in the GPX gene according to the presence of tBHP, and when the concentration of Wasong fermented extract (FOJD) was 62.5 μg/ml, the transcription amount was reduced to half.

Claims (4)

삭제delete 삭제delete 삭제delete 와송을 30℃에서 5일간 저온 건조하여 건조된 와송을 제조하는 단계;
상기 건조된 와송을 분말시켜 와송 분말을 제조하는 단계;
상기 와송 분말에 락토바실러스 플란타룸(Lactobacillus plantarum)과 과즙 배지를 첨가하여 106~107 cells/ml의 농도를 유지 시킨 균주 배양액을 0.5㎖ 접종한 뒤 30℃의 항온배양기와 진탕배양기에서 4일 동안 정치 배양하여 와송 발효추출물을 제조하는 단계; 및
산화적 스트레스를 유발하여 간염을 유발시킨 HepG2 간세포 1 x 106 cells/ml 기준으로 상기 와송 발효추출물을 100 ㎍/㎖을 포함한 식품 조성물을 제조하는 단계;를 포함하는,
산화적 스트레스에 의한 간염을 예방하는 식품 조성물의 제조방법.
Drying the wasong at 30° C. for 5 days at a low temperature to prepare a dried wasong;
preparing a wasong powder by powdering the dried wasong;
Lactobacillus plantarum ( Lactobacillus plantarum ) and fruit juice medium were added to the wasong powder to inoculate 0.5 ml of a strain culture solution maintaining a concentration of 10 6 ~ 10 7 cells/ml, and then incubate 4 in an incubator at 30° C. and a shaking incubator. Preparing a Wasong fermented extract by stationary culture for one day; and
Preparing a food composition containing 100 μg/ml of the Wasong ferment extract based on 1 x 10 6 cells/ml of HepG2 hepatocytes induced by oxidative stress to induce hepatitis;
A method for preparing a food composition for preventing hepatitis due to oxidative stress.
KR1020190119179A 2018-09-27 2019-09-26 Fermented Orostachys japonicus water extract and method of manufacturing the same to improve fuction of dameged liver by oxidative stress KR102328203B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
KR1020180115326 2018-09-27
KR20180115326 2018-09-27

Publications (2)

Publication Number Publication Date
KR20200035901A KR20200035901A (en) 2020-04-06
KR102328203B1 true KR102328203B1 (en) 2021-11-17

Family

ID=70281890

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020190119179A KR102328203B1 (en) 2018-09-27 2019-09-26 Fermented Orostachys japonicus water extract and method of manufacturing the same to improve fuction of dameged liver by oxidative stress

Country Status (1)

Country Link
KR (1) KR102328203B1 (en)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101754040B1 (en) * 2016-09-30 2017-07-05 강한은 Pharmaceutical composition for preventing or treating liver diorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100900343B1 (en) 2007-07-05 2009-06-02 조선대학교산학협력단 A Composition comprising the extract of Aralia continentalis improving cytotoxicity and liver injury for preventing and treating of liver disease

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101754040B1 (en) * 2016-09-30 2017-07-05 강한은 Pharmaceutical composition for preventing or treating liver diorders

Also Published As

Publication number Publication date
KR20200035901A (en) 2020-04-06

Similar Documents

Publication Publication Date Title
Şahin et al. Olive tree (Olea europaea L.) leaf as a waste by‐product of table olive and olive oil industry: a review
Yin et al. Antioxidant and anti-inflammatory capacity of ferulic acid released from wheat bran by solid-state fermentation of Aspergillus niger
Feng et al. Recent research process of fermented plant extract: A review
Filannino et al. Lactic acid fermentation of cactus cladodes (Opuntia ficus-indica L.) generates flavonoid derivatives with antioxidant and anti-inflammatory properties
Zhong et al. Antioxidant and anti-aging activities of mycelial polysaccharides from Lepista sordida
Karunasiri et al. Antioxidant and nutritional properties of domestic and commercial coconut milk preparations
KR101729210B1 (en) Development of antiatopic dermatitis targeted products using Abeliophyllum distichum Nakai
KR101773452B1 (en) Method for preparing fermented extraction of pine needle using steaming and drying process and cosmetic composition containing the same
KR101314762B1 (en) Manufacturing method of Fermented material extracted from ginseng seed and fermented food thereof
Chueh et al. Antioxidant capacity of banana peel and its modulation of Nrf2-ARE associated gene expression in broiler chickens
Jalil Sarghaleh et al. Evaluation of the constituent compounds, antioxidant, anticancer, and antimicrobial potential of Prangos ferulacea plant extract and its effect on Listeria monocytogenes virulence gene expression
KR20160089257A (en) Development of skin-care products Based on Antioxidative effect of Abeliophyllum distichum Nakai
Li et al. Antioxidant effect of soymilk fermented by Lactobacillus plantarum HFY01 on D-galactose-induced premature aging mouse model
Akomolafe et al. Inhibitory effect of aqueous extract of Moringa oleifera and Newbuoldia laevis leaves on ferrous sulphate and sodium nitroprusside induced oxidative stress in rat’s testes in vitro
Gündüz et al. Extraction and optimization of phenolic compounds from butterbur plant (Petasites hybridus) by ultrasound-assisted extraction and determination of antioxidant and antimicrobial activity of butterbur extracts
Lin et al. Vegetable soybean (Glycine max (L.) Merr.) leaf extracts: Functional components and antioxidant and anti‐inflammatory activities
Soto-Maldonado et al. Antioxidant and antimicrobial capacity of Maytenus boaria leaves, recovery by infusion and solvent extraction
KR102359165B1 (en) Dendropanax morbifera complex extracts for improving liver and kidney, Manufacturing method thereof and Health functional food containing the same
Yin et al. Soybean whey bio-processed using Weissella hellenica D1501 protects neuronal PC12 cells against oxidative damage
KR102139443B1 (en) Composition for inhibiting adipogenesis comprising Chrysanthemum indicum fermented by lactic acid bacteria
KR102328203B1 (en) Fermented Orostachys japonicus water extract and method of manufacturing the same to improve fuction of dameged liver by oxidative stress
Wijayanti et al. The effect of lactic acid fermentation on fig (Ficus carica) fruit flavonoid
Cheng et al. Sporidiobolus pararoseus wall-broken powder ameliorates oxidative stress in diabetic nephropathy in type-2 diabetic mice by activating the Nrf2/ARE pathway
KR20070023845A (en) Cosmetic composition comprising extracts of ginkgo biloba l. and process of manufacturing their products
Ulusoy et al. Determination of antioxidant and antimicrobial activity of sweetgum (Liquidambar orientalis) leaf, a medicinal plant

Legal Events

Date Code Title Description
E902 Notification of reason for refusal
AMND Amendment
E601 Decision to refuse application
X091 Application refused [patent]
AMND Amendment
X701 Decision to grant (after re-examination)